MedPath

Effect of intrauterine administration of granulocyte-colony stimulating factor (GCSF) in IVF cycles on the fertility rate of infertile wome

Phase 3
Conditions
Infertility.
Female infertility of other origin
N97.8
Registration Number
IRCT20110731007165N7
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
66
Inclusion Criteria

First time IVF due to infertility
Moderate to severe endometriosis (according to laparoscopic criteria, moderate endometriosis was defined as Adhesion affecting Fallopian tubes or ovaries, and severe endometriosis was defined as the involvement of Fallopian tubes, ovaries, and cul-de-sac)
Age 18-40 years
Fertility due to endometriosis
Moderate -to –severe endometriosis was characterized by endometrial glands and stroma at least 5 mm beneath the peritoneum or an ovarian endometriotic cyst (endometrioma)

Exclusion Criteria

Male factor infertility.
Evidence of a significant decrease in the ovarian reserve (FSH>11, AMH<0.5, decreased AFC),
Endocrine disorders (diabetes, thyroid diseases, hyperprolactinemia, hypothalamic amenorrhea, etc.)
, confirmed medical and immunologic diseases (SLE, rheumatoid arthritis, antiphospholipid syndrome, cardiovascular, liver, and renal diseases),
and congenital uterine anomalies and uterine cavity disorder (bicornuate uterus, unicornuate uterus, Asherman syndrome, myoma, polyps, etc.).
Donation candidates (ovum donation and surrogate utrus) were also excluded from the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy. Timepoint: 3 weeks after embryo transfer. Method of measurement: Vaginal ultrasound.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath